COMPANY OVERVIEW

Generon Corporation (Shanghai) Ltd. is an integrated biotech company developing therapeutic biologics for patients world-wide.

---

LOCATION

Shanghai, , China

---

THERAPEUTIC AREAS

---

WEBSITE

https://www.generonbiomed.com/en/

---

CAREER WEBSITE

https://www.generonbiomed.com/en/careers.shtml

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Mar 31, 2021

Evive Biotech Submits Biologics License Application to US FDA for Ryzneuta(TM)

Jul 7, 2020

Evive Biotech meets primary and secondary endpoints in global Phase III clinical trial for their novel chemotherapy-induced neutropenia treatment

Dec 8, 2018

Generon Presented Positive Phase III Results From a Double-Blind, Placebo Controlled-Clinical Trial of F-627 in Women with Breast Cancer Receiving Myelotoxic Chemotherapy

Dec 4, 2018

Generon Presented Pre-Clinical Immunotherapy Results With CD3-Activating Bi-Specific Antibody Targeting CD19 on B Cells in Mono- and Bi-Valent Format

Nov 13, 2018

Generon’s F-652 Shows Positive Results in “An Open Label, Cohort Dose Escalation Study to Assess the Safety and Efficacy in Patients with Alcoholic Hepatitis”

For More Press Releases

---